Inhibition of cardiac leptin expression after infarction reduces subsequent dysfunction

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 8, 2011, Pages 1688-1694

  Moro, C ^a   Grauzam, S ^a   Ormezzano, O ^b   Toufektsian, M C ^a   Tanguy, S ^c   Calabrese, P ^a   Coll, J L ^d   Bak, I ^e   Juhasz, B ^e   Tosaki, A ^e   de Leiris, J ^a   Boucher, F ^a  

^a LABORATOIRE TIMC IMAG   (France)

^b French Clinical Research Infrastructure Network   (France)

^c UNIVERSITY OF AVIGNON   (France)

^d INSTITUT ALBERT BONNIOT   (France)

^e UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Antisense oligodesoxynucleotides; Cytokines; Left ventricular dysfunction; Leptin; Reperfused myocardial infarction

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN;

ANIMAL; ARTICLE; DRUG EFFECT; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HEART; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RAT; TIME; WISTAR RAT;

ANIMALS; DNA, ANTISENSE; ECHOCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEPTIN; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, WISTAR; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

RATTUS;

EID: 79960308770     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01154.x     Document Type: Article

References (29)

1. Purdham DM, Zou MX, Rajapurohitam V, et al. Rat heart is a site of leptin production and action. Am J Physiol Heart Circ Physiol. 2004; 287: H2877-84.
2. Sader S, Nian M, Liu P. Leptin: a novel link between obesity, diabetes, cardiovascular risk and ventricular hypertrophy. Circulation. 2003; 108: 644-6.
3. Matsui H, Motooka M, Koike H, et al. Ischemia/reperfusion in rat heart induces leptin and leptin receptor gene expression. Life Sciences. 2007; 80: 672-80.
4. Sweeney G. Cardiovascular effects of leptin. Nat Rev Cardiol. 2010; 7: 22-9.
5. Sharma M, Mustafa S, Patel N, et al. Stimulation of cardiac fatty acid oxidation by leptin is mediated by a nitric oxide-p38 MAPK-dependent mechanism. Eur J Pharmacol. 2009; 617: 113-7.
6. Madani S, De Girolamo S, Munoz DM, et al. Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes. Cardiovasc Res. 2006; 69: 716-25.
7. Rajapurohitam V, Javadov S, Purdham DM, et al. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1. J Mol Cell Cardiol. 2006; 41: 265-74.
8. Tajmir P, Ceddia RB, Li RK, et al. Leptin increases cardiomyocyte hyperplasiaviaextracellular signal-regulated kinase- and phosphatidylinositol 3-kinase-dependent signaling pathways. Endocrinology. 2004; 145: 1550-5.
9. Xu FP, Chen MS, Wang YZ, et al. Leptin induces hypertrophyviaendothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation. 2004; 110: 1269-75.
10. Abe Y, Ono K, Kawamura T, et al. Leptin induces elongation of cardiac myocyte and causes eccentric left ventricular dilatation with compensation. Am J Physiol Heart Circ Physiol. 2007; 292: H2387-96.
11. Purdham DM, Rajapurohitam V, Zeidan A, et al. A neutralizing leptin receptor antibody mitigates hypertrophy and hemidynamic dysfunction in the post-infarcted rat heart. Am J Physiol. 2008; 295: H441-6.
12. Barouch LA, Berkowitz DE, Harrison RW, et al. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation. 2003; 108: 754-9.
13. McGaffin KR, Sun CK, Rager JJ, et al. Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury. Cardiovasc Res. 2008; 77: 54-63.
14. Smith CC, Mocanu MM, Davidson SM, et al. Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. Br J Pharmacol. 2006; 149: 5-13.
15. McGaffin KR, Zou B, McTiernan CF, et al. Leptin attenuates cardiac apoptosis after chronic ischaemic injury. Cardiovasc Res. 2009; 83: 313-24.
16. Lieb W, Sullivan LM, Harris TB, et al. Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individuals. Diabetes Care. 2009; 32: 612-6.
17. Meisel SR, Ellis M, Pariente C, et al. Serum leptin levels increase following acute myocardial infarction. Cardiology. 2001; 95: 206-11.
18. Moro C, Jouan MG, Rakotovao A, et al. Delayed expression of cytokines after reperfused myocardial infarction: possible trigger for cardiac dysfunction and ventricular remodelling. Am J Physiol. 2007; 293: H3014-9.
19. Guo Y, Jones WK, Xuan YT, et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA. 1999; 96: 11507-12.
20. Berthonneche C, Sulpice T, Boucher F, et al. New insights into the pathological role of TNF-α in early cardiac dysfunction and subsequent heart failure following myocardial infarction in rats. Am J Physiol. 2004; 287: H340-50.
21. Nickola MW, Wold LE, Colligan PB, et al. Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO. Hypertension. 2000; 36: 501-5.
22. Crooke ST, Bennett CF. Progress in antisense oligonucleotide therapeutics. Ann Rev Pharmacol Toxicol. 1996; 36: 107-29.
23. Berthonneche C, Sulpice T, Tanguy S, et al. AT1 receptor-blockade prevents cardiac dysfunction and remodeling and limits TNF-α generation early after myocardial infarction in rats. Cardiovasc Drugs Ther. 2005; 19: 251-9.
24. Maedler K, Sergeev P, Ehses JA, et al. Leptin modulates β cell expression of IL-1 receptor antagonist and release of IL-1β in human islets. Proc Natl Acad Sci. 2004; 101: 8138-43.
25. Deep Dixit V, Schaffer EM, Pyle RS, et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest. 2004; 114: 57-66.
26. Hekerman P, Zeidler J, Korfmacher S, et al. Leptin induces inflammation-related genes in RINm5F insulinoma cells. BMC Mol Biol. 2007; 8: 41, doi:.
27. Tang CH, Lu DY, Yang RS, et al. Leptin-induced IL-6 production is mediated by leptin receptor, insulin receptor substrate-1, phosphatidylinositol 3-kinase, Akt, NF-κB, and p300 pathway in microglia. J Immunol. 2007; 179: 1292-302.
28. Sachs HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J. 2007; 153: 907-17.
29. Knudson JD, Payne GA, Borbouse L, et al. Leptin and mechanisms of endothelial dysfunction and cardiovascular disease. Curr Hypertens Rep. 2008; 10: 434-9.